): A. Purpose and Program Characteristics - The purpose of this program is to provide postdoctoral training to individuals wishing to pursue basic research in the pathobiology of cancer. The program is designed to achieve maximum faculty participation and specifically strives to foster a working knowledge of the interface between cancer cell biology, cancer diagnostics, and cancer therapy. The applicants' goal is to produce highly focused independent investigators capable of productive collaboration with other basic scientists and with clinical colleagues involved in the study and treatment of cancer. T h e p rimary means of achieving this goal are an interactive and multidisciplinary research faculty, a formal Tumor Biology Curriculum which integrates current concepts in cell growth control with those of human carcinogenesis, and a weekly workshop in which trainees discuss their research with fellow trainees, with members of the training grant faculty, and with the Mayo scientific community at large. B. Trainees - Nine postdoctoral trainees are requested to participate for each of five years. Individuals holding the Ph.D. and/or M.D. degrees are eligible and are selected on the basis of academic record, research experience, career goals, letters of recommendation, and motivation for academic research. C. Training Facilities - The research laboratories of individual investigators constitute the primary training facilities. These are located within the Departments/Divisions of Biochemistry and Molecular Biology, Immunology, Pharmacology, Developmental Oncology Research, Urology Research, Experimental Pathology, and Laboratory Medicine, and Thoracic Diseases Research. These Departments/Divisions are all located within the Guggenheim Building for Basic Biomedical Research and are supported by institutional Shared Research Resource Facilities in Analytical NMR, Electron Microscopy, Mass Spectroscopy, Molecular Biology, Radioimmunoassay, Pharmacology, Cancer Biostatistics, Biomedical Imaging, Flow Cytometry/Optical Morphometry, Mathematical Methods, Protein Sequencing/Peptide Synthesis, Research Computing, Cytogenetics, and Pathology. Separate facilities are available for animal housing, engineering, and classroom and lecture space.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009441-19
Application #
6375524
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
1988-06-01
Project End
2003-03-31
Budget Start
2001-08-24
Budget End
2002-03-31
Support Year
19
Fiscal Year
2001
Total Cost
$405,782
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Pettit, George R; Searcy, Justin D; Tan, Rui et al. (2016) Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications. J Nat Prod 79:507-18
Pettit, George R; Rosenberg, Heidi J; Dixon, Rachel et al. (2012) Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs. J Nat Prod 75:385-93
Pettit, Robin K; Repp, Kimberly K; Hazen, Kevin C (2010) Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents. Med Mycol 48:421-6
Pettit, George R; Meng, Yanhui; Pettit, Robin K et al. (2010) Antineoplastic agents. 556. Isolation and structure of Coprinastatin 1 from Coprinus cinereus. J Nat Prod 73:388-92
Pettit, George R; Minardi, Mathew D; Hogan, Fiona et al. (2010) An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins. J Nat Prod 73:399-403
Pettit, George R; Thornhill, Andrew; Melody, Noeleen et al. (2009) Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs. J Nat Prod 72:380-8
Pettit, George R; Melody, Noeleen; Thornhill, Andrew et al. (2009) Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification. J Nat Prod 72:1637-42
Novak, Anne J; Darce, Jaime R; Arendt, Bonnie K et al. (2004) Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 103:689-94
Rowley, Matthew; Grothey, Erin; Couch, Fergus J (2004) The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia 9:109-18
Monroe, D G; Johnsen, S A; Subramaniam, M et al. (2003) Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines. J Endocrinol 176:349-57

Showing the most recent 10 out of 85 publications